Yong Yi

839 total citations
43 papers, 630 citations indexed

About

Yong Yi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yong Yi has authored 43 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Yong Yi's work include Antibiotic Resistance in Bacteria (4 papers), Escherichia coli research studies (3 papers) and Protein Degradation and Inhibitors (3 papers). Yong Yi is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Escherichia coli research studies (3 papers) and Protein Degradation and Inhibitors (3 papers). Yong Yi collaborates with scholars based in China, United States and Hong Kong. Yong Yi's co-authors include Patrick C. Y. Woo, Bin Li, Cui Hua Liu, Yongfei Hu, Baoli Zhu, Long‐Fei Wu, Tengwei Song, Changyou Chen, Jing Hua and Qi Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yong Yi

37 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Yi China 15 167 162 149 65 64 43 630
Nadine Taudte Germany 10 229 1.4× 71 0.4× 72 0.5× 94 1.4× 39 0.6× 16 810
Karen Poon Canada 16 460 2.8× 89 0.5× 69 0.5× 68 1.0× 82 1.3× 30 1.0k
Athanasios Paschos Canada 16 409 2.4× 66 0.4× 76 0.5× 80 1.2× 96 1.5× 27 1.1k
Shuo Lu China 19 275 1.6× 196 1.2× 76 0.5× 53 0.8× 13 0.2× 44 1.1k
David G. Kehres United States 15 420 2.5× 79 0.5× 127 0.9× 30 0.5× 90 1.4× 18 1.4k
Huizhong Liu China 16 237 1.4× 47 0.3× 60 0.4× 51 0.8× 44 0.7× 34 537
Vincent Bonifay United States 14 226 1.4× 166 1.0× 44 0.3× 46 0.7× 11 0.2× 24 683
Daniel Raimunda United States 14 225 1.3× 79 0.5× 27 0.2× 93 1.4× 56 0.9× 21 929

Countries citing papers authored by Yong Yi

Since Specialization
Citations

This map shows the geographic impact of Yong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yi more than expected).

Fields of papers citing papers by Yong Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yi. The network helps show where Yong Yi may publish in the future.

Co-authorship network of co-authors of Yong Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Yi. A scholar is included among the top collaborators of Yong Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Yi. Yong Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Su, Yuan, Yong Yi, Zi Wang, et al.. (2025). Circular RNAs derived from MIR156D promote rice heading by repressing transcription elongation of pri-miR156d through R-loop formation. Nature Plants. 11(4). 709–716. 2 indexed citations
3.
Fei, Junjie, Mingzhe Xu, Xueqing Li, et al.. (2025). Energy stress-induced PKCζ S-glutathionylation is essential for LKB1 cytoplasmic translocation and AMPK activation. PubMed. 4(6). loaf027–loaf027. 1 indexed citations
4.
Huang, Xiaoyong, Qiang Gao, Fei Liang, et al.. (2024). Two stage, multi-center trial of cadonilimab and LM-302 for patients with CLDN18.2+ biliary tract cancer (BTC) that failed chemotherapy and PD-(L)1 antibody (ZSAB-Calm).. Journal of Clinical Oncology. 42(16_suppl). e16152–e16152. 2 indexed citations
5.
Yi, Yong, Tingting Li, Mei‐Chin Hsieh, et al.. (2024). Impact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in Louisiana. Cancer Medicine. 13(12). e7301–e7301.
6.
Jiang, Jingcheng, Han Wang, Qingshan Deng, et al.. (2024). Bilateral Simultaneous Basal Ganglia Hemorrhage: A Case Report. American Journal of Case Reports. 25. e943174–e943174.
7.
Zhou, Cheng, Bao‐Ye Sun, Pei‐Yun Zhou, et al.. (2023). MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway. Clinical Immunology. 256. 109770–109770. 20 indexed citations
8.
Palacino, James, Pedro Lee, Yeonjoon Kim, et al.. (2023). Abstract 2700: ORM-6151: A first-in-class CD33-antibody enabled GSPT1 degrader for AML. Cancer Research. 83(7_Supplement). 2700–2700. 5 indexed citations
9.
Wang, Mingxia, Chaowei Zhong, Enzhu Li, et al.. (2022). Glass-free Li2SiO3-LiF ceramics with high thermal conductivity. Materials Today Communications. 33. 104796–104796. 1 indexed citations
10.
Peng, Jian, Haisheng Han, Yong Yi, Huimin Huang, & Le Xie. (2022). Machine learning and deep learning modeling and simulation for predicting PM2.5 concentrations. Chemosphere. 308(Pt 1). 136353–136353. 60 indexed citations
11.
Yi, Yong, Bao‐Ye Sun, Jialei Weng, et al.. (2022). Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study. Frontiers in Oncology. 12. 1046584–1046584. 21 indexed citations
12.
Lyons, John, et al.. (2022). Trends in hepatocellular carcinoma in Louisiana, 2005–2015. SHILAP Revista de lepidopterología. 1. 100041–100041. 1 indexed citations
13.
Chen, Changyou, et al.. (2016). Killing of Staphylococcus aureus via Magnetic Hyperthermia Mediated by Magnetotactic Bacteria. Applied and Environmental Microbiology. 82(7). 2219–2226. 43 indexed citations
14.
15.
Chen, Changyou, et al.. (2014). Construction of a microrobot system using magnetotactic bacteria for the separation of Staphylococcus aureus. Biomedical Microdevices. 16(5). 761–770. 40 indexed citations
16.
Yi, Yong, Na Lü, Fei Liu, et al.. (2014). Genome sequence and comparative analysis of a Vibrio cholerae O139 strain E306 isolated from a cholera case in China. Gut Pathogens. 6(1). 3–3. 9 indexed citations
17.
Du, Wei, Yong Yi, Haibo Zhang, et al.. (2013). Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy. PLoS ONE. 8(12). 4 indexed citations
18.
Yi, Yong, Ying Ma, Feng Gao, et al.. (2010). Crystal Structure of EHEC Intimin: Insights into the Complementarity between EPEC and EHEC. PLoS ONE. 5(12). e15285–e15285. 16 indexed citations
19.
Gu, Jiang, Yanqing Liu, Shu Yu, et al.. (2009). Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes and Infection. 11(10-11). 835–841. 36 indexed citations
20.
Yi, Yong & Zhongyuan Lu. (2006). Design of magnetic suspension system for ICF target. High Power Laser and Particle Beams. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026